1. Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N.. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):248-654. https://doi.org/10.1183/09031936.00102509
2. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD Assessment Test: a systematic review. Eur Respir J. 2014; 44(4): 873-884. https://doi.org/10.1183/09031936.00025214
3. Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) following acute exacerbations and pulmonary rehabilitation. Chest. 2012;142(1):134-140. https://doi.org/10.1378/chest.11-0309
4. Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 2011;66(5):425-429. https://doi.org/10.1136/thx.2010.156372
5. Global Initiative for Chronic Obstructive Pulmonary Disease. 2025 Global strategy for prevention, diagnosis, and management of COPD. Published 2025. Accessed February 2025. https://www.gold.org
6. Thomashow B, Crapo J, Yawn B, et al. The COPD Foundation Pocket Consultant Guide. Chronic Obstr Pulm Dis. 2014;1(1): 83-87. https://doi.org/10.15326/jcopdf.1.1.2014.0124
7. Woodruff, PG, Barr G, Bleeker E, et al; SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. New Eng J Med. 2016; 374(19): 1811-1821 https://doi.org/10.1056/NEJMoa1505971
8. McKleroy W, Shing T, Andersen WH, et al. Longitudinal follow-up of participants with tobacco exposure and preserved spirometry. JAMA. 2023; 330(5): 442-453. https://doi.org/10.1001/jama.2023.11676
9. Lanza FC, Castro RAS, de Camargo AA, et al. COPD Assessment Test (CAT) is a valid and simple tool to measure the impact of bronchiectasis on affected patients. COPD. 2018;15(5):512-519. https://doi.org/10.1080/15412555.2018.1540034
10. Finch S, Laska IF, Abo-Leyah H, Fardon TC, Chalmers JD. Validation of the COPD Assessment Test (CAT) as an outcome measure in bronchiectasis. Chest. 2020;157(4):815-823. https://doi.org/10.1016/j.chest.2019.10.030
11. Brill SE, Patel AR, Singh R, Mackay AJ, Brown JS, Hurst JR. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Res. 2015;16(1):16. https://doi.org/10.1186/s12931-015-0167-9
12. Matsuda T, Kondoh Y, Furukawa T, et al. The prognostic value of the COPD Assessment Test in fibrotic interstitial lung disease. Respir Investig. 2022;60(1):99-107. https://doi.org/10.1016/j.resinv.2021.07.007
13. Matsuda T, Kondoh Y, Takei R, et al. Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease. Respir Investig.2024;62(6): 1088-1093. https://doi.org/10.1016/j.resinv.2024.08.006
14. Tamaki K et al. Utility of self-administered questionnaires for identifying individuals at risk of COPD in Japan: the OCEAN (Okinawa COPD casE finding AssessmeNt) Study. Int J Chron Obstruct Pulmon Dis. 2021;16: 1771-1782. https://doi.org/10.2147/COPD.S302259
15. Reddel HK, Vestbo J, Agustí A, et al. Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. Eur Respir J. 2021;58(3):2003927. https://doi.org/10.1183/13993003.03927-2020
16. Tomaszewski EL, Atkinson MJ, Janson C, et al; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023;24(1):106 https://doi.org/10.1186/s12931-023-02394-6
17. Jones PW, Tomaszewski E, Belton L, et al; NOVELTY Scientific Community; NOVELTY study investigators. Validity of the Chronic Airways Assessment Test (CAAT) in asthma, asthma+COPD and COPD in NOVELTY. ERJ Open Res. 2025; In press. https://doi.org/10.1183/23120541.01359-2024
18. Mapi Research Trust. eProvide platform. Mapi Research Trust website. Updated 2025. Accessed May 2025. https://eprovide.mapi-trust.org/my-eprovide/my-requests
19. Müllerová H, Dransfield MT, Thomashow B, et al. Clinical development and research applications of the chronic obstructive pulmonary disease assessment test. Am J Respir Crit Care Med. 2020;201(9):1058-1067. https://doi.org/10.1164/rccm.201907-1369PP
20. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14: 902–907. https://doi.org/10.1034/j.1399-3003.1999.14d29.x
21. GSK group of companies. Welcome to the Asthma Control Test. Asthma Control Test website. Published 2024. Accessed May 2025. https://www.asthmacontroltest.com